Patents by Inventor Cecilia Nilsson

Cecilia Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of CGRP
    Patent number: 8835379
    Abstract: Acylated CGRP compounds with a linker have prolonged action and are valuable as medicaments.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: September 16, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Anette Sams Nielsen, Thomas Kruse, Janos Tibor Kodra, Jesper F. Lau, Jacob Kofoed, Kirsten Raun, Cecilia Nilsson
  • LONG-ACTING Y2 RECEPTOR AGONISTS
    Publication number: 20130096055
    Abstract: The present invention relates to PYY derivatives comprising a serum albumin binding side chain, wherein said derivative has a half-life of at least 7 hours as determined by Assay (IV) described herein as well as compositions comprising said derivative and its use in therapy.
    Type: Application
    Filed: November 15, 2010
    Publication date: April 18, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Jacob Kofoed, Lars Ynddal, Soeren Oestergaard, Rasmus Joergensen, Flemming Sejer Nielsen, Cecilia Nilsson, Jens Kaalby Thomsen
  • Derivatives of CGRP
    Publication number: 20120245083
    Abstract: Acylated CGRP compounds with a linker have prolonged action and are valuable as medicaments.
    Type: Application
    Filed: October 27, 2010
    Publication date: September 27, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Anette Sams Nielsen, Thomas Kruse, Janos Tibor Kodra, Jesper F. Lau, Jacob Kofoed, Kirsten Raun, Cecilia Nilsson
  • Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1
    Publication number: 20070066614
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: November 20, 2006
    Publication date: March 22, 2007
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt
  • Inhibitors of 11-?-hydroxy steroid dehydrogenase type 1
    Patent number: 7173030
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: February 6, 2007
    Assignee: Biovitrum AB
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt
  • Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
    Publication number: 20050009821
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: May 21, 2004
    Publication date: January 13, 2005
    Inventors: David Pyring, Martin Henriksson, Jan Vagberg, Meredith Williams, Cecilia Nilsson, Catrine Dreifeldt